SARS-CoV-2 spike protein: flexibility as a new target for fighting infection

Signal Transduct Target Ther. 2020 Oct 30;5(1):254. doi: 10.1038/s41392-020-00369-3.

Author

Ciro Leonardo Pierri^{1

2}

Affiliations

¹ Laboratory of Biochemistry; Molecular and Structural Biology; Department of Biosciences, Biotechnologies, Biopharmaceutics, University of Bari, Via E. Orabona, 4, 70125, Bari, Italy. ciro.pierri@uniba.it.
² BROWSer S.r.l. (https://browser-bioinf.com/) c/o Department of Biosciences, Biotechnologies, Biopharmaceutics, University "Aldo Moro" of Bari, Via E. Orabona, 4, 70126, Bari, Italy. ciro.pierri@uniba.it.

No abstract available

Publication types

Comment

MeSH terms

Betacoronavirus
COVID-19
Coronavirus Infections*
Humans
Pandemics*
Pneumonia, Viral*
SARS-CoV-2
Spike Glycoprotein, Coronavirus / genetics

Substances

Spike Glycoprotein, Coronavirus
spike protein, SARS-CoV-2